By Lucy Parkinson, Director of Research, LSN
The healthcare investment world is just over 90 days out from the annual San Francisco conference week, and investors are already inking their plans for a busy week. Within that hectic JPM ecosystem, RESI SF is a key venue to meet with early stage startups, and many investors are already made their plans to attend.
LSN would like to make our first RESI San Francisco panel announcement: Healthcare IT Investors. This panel focuses on investors that are looking for innovative startups using software to solve healthcare problems, from drug discovery and development to care provision and management. Significant investment is pouring into this sector, with an estimated $4.5 billion invested in 2015. At RESI, we’ll hear from 5 highly active investors from a diverse variety of firms on what they’re looking for in healthcare IT at present, and how an opportunity can catch their attention.
The participants will be:
- Edward Kliphuis, Investment Director, Merck Ventures
- Momei Qu, Vice President, Baird Venture Partners
- Akhil Saklecha, Partner, Artiman Ventures
- David Kim, CEO, DigiTx Partners
- Lana Ghanem, Managing Director, Hikma Ventures
Join us at RESI to hear from these experienced investors discuss how they search for and assess healthcare IT opportunities, and what areas of this diverse sector are most attractive at present.